| Patient | Ann Richards |
|---|---|
| Date of birth | 1962-09-01 |
| Identifiers | MRN HR-ML019-SYN; SSN (made up) 000-19-3381 |
| Document date | 2026-10-06 |
| Author | Rosalind Teague, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Adult preventive visit; no new complaints. [S]
Ms. Richards is a 64-year-old woman who returns for her yearly preventive visit, eight weeks after her six-month bone health review. She has low bone mass with a high 10-year fracture risk and had her first yearly zoledronic acid infusion in May. She takes vitamin D3 2000 units a day and gets about 1200 mg of calcium a day from food. She keeps up the home balance program three times a week, walks most days, and lifts weights twice a week. She has had no falls. She has had no alcohol and remains in sustained remission. She completed the health risk assessment before the visit and has no new concerns. [S]
| Element | Detail |
|---|---|
| Visit | Adult preventive visit |
| Safety events | No falls, fractures, emergency visits, or hospital stays this year |
| Medicines | Vitamin D3 2000 units daily; zoledronic acid once a year (next dose in May); no over-the-counter sleep aids or sedatives |
| Active conditions | Low bone mass with high fracture risk, on treatment; alcohol use disorder in sustained remission; history of falls, none this year |
| Functional status | Independent; travels most weeks for work |
Health risk assessment. Completed by the patient before the visit and reviewed during the visit. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Very good |
| Psychosocial | Busy with speaking and advisory work; close family and friends; no loneliness; stress manageable |
| Tobacco | Former smoker; no tobacco or vaping for more than fifteen years |
| Alcohol and drugs | No alcohol (AUDIT-C 0); no other drug use; recovery steady |
| Physical activity | Walks 30 minutes most days, weight training twice a week, balance routine three times a week |
| Nutrition | About 1200 mg of calcium a day from food; protein at each meal; two cups of coffee a day |
| Sleep | About seven hours a night; some short nights when traveling |
| Activities of daily living | Independent |
| Instrumental activities of daily living | Independent, including driving, finances, and medicines |
| Home safety | Stair rails on both sides, night lights, no loose rugs; smoke detectors working; seat belt always |
| Falls | No falls this year; less fear of falling since the balance program |
| Hearing and vision | Reading glasses; eye examination this year; no hearing difficulty |
| Memory | No concerns |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Weight stable; no fever, night sweats, or unusual fatigue |
| Eyes | Negative | No change in vision with reading glasses |
| Ears, nose, mouth, and throat | Negative | No hearing change; no jaw pain, loose teeth, or mouth sores |
| Cardiovascular | Negative | No chest pain, palpitations, or ankle swelling |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No abdominal pain, swallowing difficulty, or change in bowel habit |
| Genitourinary | Negative | No urinary symptoms; no postmenopausal bleeding |
| Musculoskeletal | Negative | No bone, back, hip, or thigh pain; no new fracture |
| Integumentary | Negative | No new or changing skin lesions |
| Neurological | Negative | No dizziness, weakness, or numbness |
| Psychiatric | Negative | Mood good; no cravings; PHQ-2 score 0 |
| Breast | Negative | No lump, pain, or nipple discharge |
12 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Cholecalciferol (vitamin D3) 50 mcg (2000 units) oral tablet, one tablet daily | One tablet by mouth daily | Oral route | 2026-02-10 | active | S |
| Zoledronic acid 5 mg in 100 mL intravenous infusion over 30 minutes, once every 12 months | Once every 12 months, given in the clinic infusion room after a calcium and creatinine check | Intravenous route | 2026-05-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets every 6 hours as needed for aches or fever for up to three days after the infusion (no more than 3 g a day) | Two tablets every 6 hours as needed for up to three days after the infusion | Oral route | 2026-05-12 to 2026-05-15 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-10-06 | Body height | 164 | cm | S |
| 2026-10-06 | Body weight | 65.8 | kg | S |
| 2026-10-06 | Body mass index (BMI) [Ratio] | 24.5 | kg/m2 | S |
| 2026-10-06 | Systolic blood pressure | 122 | mm[Hg] | S |
| 2026-10-06 | Diastolic blood pressure | 74 | mm[Hg] | S |
| 2026-10-06 | Heart rate | 70 | /min | S |
| 2026-10-06 | Respiratory rate | 14 | /min | S |
| 2026-10-06 | Body temperature | 36.6 | Cel | S |
| 2026-10-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-10-06 | Cholesterol [Mass/volume] in Serum or Plasma | 204 | mg/dL | <=199 mg/dL | High | S |
| 2026-10-06 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 62 | mg/dL | >=50 mg/dL | Normal | S |
| 2026-10-06 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 118 | mg/dL | <=129 mg/dL | Normal | S |
| 2026-10-06 | Triglyceride [Mass/volume] in Serum or Plasma | 120 | mg/dL | <=149 mg/dL | Normal | S |
| 2026-10-06 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S | ||
| 2026-10-06 | Total score [AUDIT-C] | 0 | {score} | S |
Vital signs recorded on 2026-10-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Well and energetic; weight 65.8 kg, BMI 24.5; stadiometer height 164.0 cm, unchanged since February |
| Eyes | Pupils equal and reactive; near vision 20/25 with reading glasses |
| Ears, nose, and throat | Canals clear; whispered-voice test passed on both sides; good dentition, no exposed bone |
| Neck | No thyroid enlargement or nodes |
| Breasts | Clinical breast examination offered and declined; no concerns reported |
| Cardiovascular | Regular rhythm at 70 per minute; no murmur; no edema |
| Respiratory | Clear to auscultation |
| Abdomen | Soft and non-tender; no masses |
| Musculoskeletal | No spinal tenderness or kyphosis; occiput touches the wall; Timed Up and Go 9 seconds; tandem stance 20 seconds |
| Neurological | Alert and oriented; gait steady |
| Psychiatric | Euthymic, engaged, and quick-witted |
| Skin | No suspicious lesions |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Low bone mass (osteopenia) of the lumbar spine and hip on DXA, lowest T-score -2.3 at the lumbar spine (femoral neck -2.0, total hip -1.7), with a 10-year FRAX risk above the treatment thresholds (major osteoporotic fracture 22 percent, hip 3.6 percent); not osteoporosis by T-score, but meets the AACE 2020 clinical criteria for osteoporosis (low bone mass with a FRAX risk above threshold) | active | confirmed | M85.89 | S — Synthetic modern DXA and FRAX classification linked to her publicly described osteopenia (early osteoporosis) after a fall with a hand fracture. |
| Alcohol use disorder in sustained remission for more than fifteen years, since treatment; no alcohol since | active | confirmed | F10.21 | S — Synthetic modern coding of her publicly described heavy drinking and long recovery; listed because remission protects bone and lowers fall risk, and it is reviewed at each visit. |
| History of falls: a fall from standing height with a hand fracture last year (and, in one account, a second fall with an ankle fracture); no falls since | active | confirmed | Z91.81 | S — Synthetic modern entry linked to her publicly described falls and fractures. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, this season | Completed today | Inactivated vaccine given today |
| Pneumococcal vaccine | Completed today | PCV20 given today; recommended once for all adults 50 and older; no further dose needed |
| COVID-19 vaccine, this season | Due | Recommended; she will get it at her pharmacy this month |
| Recombinant zoster vaccine | Up to date | Two-dose series completed three years ago |
| Tetanus, diphtheria, and pertussis booster | Up to date | Tdap seven years ago; next due in about three years |
| RSV vaccine | Not indicated | Recommended at 50 to 74 only with a risk condition; she has none |
| Breast cancer screening | Up to date | Screening mammogram every two years from 40 to 74; last normal 14 months ago; next in about ten months |
| Cervical cancer screening | Up to date | HPV test negative three years ago with earlier normal results; screening can stop after 65 with adequate negative results |
| Colorectal cancer screening | Up to date | Colonoscopy normal six years ago; next in four years |
| Lung cancer screening | Not indicated | Former heavy smoker, but she quit more than 15 years ago, so she does not meet the criteria |
| Cholesterol screening and statin decision | Completed today | LDL 118 mg/dL; 10-year risk about 5 percent; no statin; recheck in five years or if risk changes |
| Diabetes screening | Not indicated | Recommended at 35 to 70 with overweight or obesity; BMI 24.5 |
| Blood pressure screening | Completed today | 122/74 mmHg |
| Hepatitis C and HIV screening | Up to date | One-time screening for both done in the past, negative |
| Depression screening | Completed today | PHQ-2 score 0; PHQ-9 2 in February |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 0; sustained remission |
| Tobacco use | Completed today | Former smoker; no use |
| Osteoporosis screening | Not indicated | Already diagnosed and on treatment; follow-up DXA two years after starting |
| Falls prevention | Completed today | No falls; Timed Up and Go 9 seconds; home balance program continues |
| Physical activity and diet counseling | Completed today | Weight-bearing, strength, and balance exercise; calcium from food |
| Eye examination | Up to date | Done this year |
Immunizations given today: Influenza vaccine, 2026-2027 season; Pneumococcal conjugate vaccine PCV20, single dose [S]
Guideline basis: CMID: Clinical Monitoring Intelligence Database, osteoporosis monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Adult Immunization Schedule by Age (2026)
Follow-up: COVID-19 vaccine at her pharmacy. Mammogram in about ten months. Second zoledronic acid dose in May with pre-infusion tests. Next preventive visit in one year. [S]
Voluntary advance care planning discussion of about 20 minutes, with her consent. We talked about why it helps to choose a health care agent and to put wishes in writing while she is well. She named a health care agent, who is recorded in the chart and not named here, and took a medical power of attorney form and a directive form home to complete. She said what matters most to her is staying independent and being told the plain truth about her health so she can make her own decisions. She chose not to record specific treatment preferences today. The plan will be revisited next year or sooner if her health changes. [S]